Persephone Biosciences
We are a synthetic biology company developing a platform to industrialize and scale the microbiome.
We are a synthetic biology company developing a platform to industrialize and scale the microbiome.
Persephone Biosciences is a synthetic biology company founded in 2017 with a mission to industrialize and scale the microbiome. The company is focused on utilizing synthetic biology for microbial products that have a positive impact on patient and infant health. Their end-to-end platform is designed to industrialize the development of engineered cells that contribute to the restoration of health in damaged human ecosystems. The recent $15.00M Seed Round investment on 19 July 2022 has garnered significant attention, with prominent investors such as Susa Ventures, Y Combinator, Pioneer Fund, ZhenFund, 50Y, North South Ventures, Propel Bio Partners, First Bight Ventures, and BrightEdge Fund showing confidence in the company's vision. Headquartered in the United States, Persephone Biosciences represents the future of synthetic biology in the AI, Biotechnology, and Health Care industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $15.00M | 9 |
|
19 Jul 2022 |
| Seed Round | Unknown | 1 |
|
15 Mar 2018 |
| Pre Seed Round | $120.00K | - | 04 Jan 2018 |
No recent news or press coverage available for Persephone Biosciences.
We care about your data, and we'd love to use cookies make your experience better.
